Sciences Inc Gilead serves as Executive at ACHILLION PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Sciences Inc Gilead has executed 2 insider transactions totaling $220.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 31, 2021 involved purchasing 5,650,000 shares valued at $220.3M.
Sciences Inc Gilead currently holds 13,913,029 shares of ACHILLION PHARMACEUTICALS INC (ACHN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sciences Inc Gilead has been a net buyer of ACHN stock. They have purchased $220.3M and sold $0 worth of shares.
Sciences Inc Gilead's most recent insider trade was on Jan 31, 2021, when they purchased 5,650,000 shares at $39.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |